10/07/19
A new trial being undertaken by the NHMRC Clinical Trials Centre is photographing the back of the eye of those living with diabetes to help them avoid losing their vision and the risks of amputation and heart disease.
14/06/19
The ANZUP-led ENZAMET trial was a stand-out success story at the recent American Society of Clinical Oncology annual conference.
24/05/19
CTC’s partnership with Miracle Babies Foundation - a consumer body representing parents of sick newborns - has received the Australian Clinical Trials Alliance’s inaugural award for consumer engagement.
02/04/19
In a long awaited study on preterm babies, the CTC and its partners have taken a pioneering path to ensure they get enough trial participants and can positively impact babies lives around the word.
11/03/19
Statin therapy is safe and effective in older people over 75 years and reduces major cardiovascular events such as heart attacks and strokes, according to new research by the University of Sydney's Clinical Trials Centre published in The Lancet.
10/01/19
Eleven CTC investigators were awarded new funding from the NHMRC, the ARC, the MRFF, Cure Brain Cancer, and the Danish Diabetes Academy.
13/12/18
CTC leads review of cost-effectiveness for screening and vaccinating migrants for European Union.
13/09/18
Pancreatic cancer could be treated using a new form of radiotherapy that delivers highly targeted doses of radiation to kill tumour cells.
30/07/18
The award was established to celebrate exceptional performance at the University of Sydney.
25/07/18
The Cooperative Trials Group for Neuro-Oncology (COGNO) at the CTC was awarded funding from CanTeen to give adolescent and young adult cancer patients access to the latest in treatment.
25/07/18
In a recent review article, the CTC joins calls for better access to blood glucose meters and test strips for diabetes sufferers.
31/05/18
Congratulations to the CTC's Mbathio Dieng, who won a prestigious University of Sydney Faculty of Medicine Award for her PhD research into managing stress and fear of cancer recurrence in recovering, early-stage melanoma patients.
16/05/18
A life-saving placental transfusion study led by CTC's Professor William Tarnow-Mordi received the Australian Clinical Trials Alliance 'Trial of the Year' Award.
31/07/17
A report authored by ACTA and an Australian Commission says trials return $5.80 for every $1 invested.